We are live on ! Find out more
NC

Nicholas Company Portfolio holdings

AUM $5.1B
1-Year Est. Return 8.43%
This Fund
S&P 500
This Quarter Est. Return
+8.82%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.75B
AUM Growth
+$308M
Cap. Flow
-$43.6M
Cap. Flow %
-0.92%
Top 10 Hldgs %
20.23%
Holding
229
New
8
Increased
75
Reduced
111
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Healthcare 19%
3 Consumer Discretionary 14.42%
4 Financials 13.75%
5 Industrials 13.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CB icon
26
Chubb
CB
$137B
$52.2M 1.1%
335,500
+60
+0% +$9.18K
LH icon
27
Labcorp
LH
$23.1B
$51.8M 1.09%
356,388
-64
-0% -$9.24K
SBUX icon
28
Starbucks
SBUX
$119B
$49.4M 1.04%
561,740
-85
-0% -$7.25K
SNA icon
29
Snap-on
SNA
$21.1B
$48.3M 1.02%
284,875
-65
-0% -$10.6K
PANW icon
30
Palo Alto Networks
PANW
$284B
$47.7M 1%
1,236,690
-330
-0% -$12.5K
LLY icon
31
Eli Lilly
LLY
$1.02T
$45.8M 0.96%
348,325
+53,950
+18% +$6.25M
SPGI icon
32
S&P Global
SPGI
$133B
$43.8M 0.92%
160,465
-25
-0% -$6.5K
BSX icon
33
Boston Scientific
BSX
$65.1B
$42.4M 0.89%
937,885
+65
+0% +$2.72K
META icon
34
Meta Platforms (Facebook)
META
$1.64T
$42.2M 0.89%
205,570
JPM icon
35
JPMorgan Chase
JPM
$901B
$42M 0.89%
301,465
-2,225
-0.7% -$285K
IT icon
36
Gartner
IT
$9.44B
$41.9M 0.88%
271,725
+10,165
+4% +$1.55M
KO icon
37
Coca-Cola
KO
$353B
$41.7M 0.88%
752,650
+90
+0% +$4.84K
UNH icon
38
UnitedHealth
UNH
$383B
$41.6M 0.88%
141,580
+5,050
+4% +$1.32M
PEP icon
39
PepsiCo
PEP
$185B
$39.5M 0.83%
288,920
-60
-0% -$8.17K
MDLZ icon
40
Mondelez International
MDLZ
$77.4B
$39.4M 0.83%
714,525
-1,105
-0.2% -$59.1K
BDX icon
41
Becton Dickinson
BDX
$42.6B
$38.9M 0.82%
146,483
-25
-0% -$6.23K
HON icon
42
Honeywell
HON
$71.7B
$38.2M 0.81%
229,208
-42
-0% -$6.87K
PARA
43
DELISTED
Paramount Global Class B
PARA
$37.3M 0.78%
+887,550
New +$34.4M
MCD icon
44
McDonald's
MCD
$190B
$36.1M 0.76%
182,930
-30
-0% -$5.95K
FISV
45
Fiserv Inc
FISV
$27.6B
$36M 0.76%
311,525
-180,963
-37% -$20M
PFE icon
46
Pfizer
PFE
$141B
$35.5M 0.75%
956,141
+184
+0% +$6.55K
AMGN icon
47
Amgen
AMGN
$197B
$35.1M 0.74%
145,420
-25
-0% -$5.51K
ALC icon
48
Alcon
ALC
$34.2B
$34.6M 0.73%
612,055
+40,565
+7% +$2.32M
ROK icon
49
Rockwell Automation
ROK
$51B
$34.6M 0.73%
170,495
-25
-0% -$4.63K
GILD icon
50
Gilead Sciences
GILD
$165B
$34M 0.72%
523,675
+5,150
+1% +$335K

Similar funds

Nicholas Company's Q4 2019 Portfolio in Review

As of Q4 2019, Nicholas Company held 229 positions worth $4.75B, up 7% from $4.44B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Nicholas Company's Q4 2019 filing shows 8 new, 75 increased, 111 reduced and 9 closed positions. Its largest new stake was Paramount Global Class B: 887,550 shares worth $37.3M. The largest sale was Albemarle, an estimated $32.7M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Nicholas Company's largest Q4 2019 buy was Paramount Global Class B: 887,550 shares worth $37.3M.
  • Nicholas Company added most to Eli Lilly in Q4 2019, an estimated $6.25M increase.
  • Nicholas Company's biggest Q4 2019 reduction was Charles Schwab, cutting an estimated $20.9M.
  • Nicholas Company fully exited Albemarle in Q4 2019, selling an estimated $32.7M.
  • Nicholas Company's ten largest holdings make up 20% of its $4.75B portfolio in Q4 2019.
  • Nicholas Company opened 8 new positions and closed 9 in Q4 2019.
  • Nicholas Company's portfolio value rose 7% quarter-over-quarter to $4.75B.

Based on Nicholas Company's 13F filing for Q4 2019, filed 13 Feb 2020.